Development and in vitro evaluation of theophylline loaded matrix tablets prepared with direct compression

dc.authorid0000-0002-3210-3747
dc.contributor.authorEge, Mehmet Ali
dc.contributor.authorÜstünda? Okur, Neslihan
dc.contributor.authorKarasulu, Hatice Yeşim
dc.contributor.authorGüneri, Tamer
dc.date.accessioned2020-07-16T07:00:33Z
dc.date.available2020-07-16T07:00:33Z
dc.date.issued2016
dc.departmentİstanbul Medipol Üniversitesi, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümü, Farmasötik Teknoloji Ana Bilim Dalı
dc.description.abstractThe objectives of the present study are to develop novel sustained release matrix tablets of theophylline and to evaluate release properties and kinetic behaviour of these tablets. The formulations have been prepared in order to improve their dissolution properties in terms of providing better oral absorption of theophylline. Therefore, the effects of the components’ nature and their proportion in the release rate were investigated. Theophylline loaded tablets were prepared with direct compression using Compritol® ATO 33 and Hydroxypropyl methylcellulose (HPMC E50) with different amounts and then they were evaluated for their in vitro drug release profiles. According the evaluation of drug release profiles, it has seen that Compritol® ATO 33 and HPMC-E50 ratio changed the release profile of theophylline. The dissolution of tablets was determined by using USP XXIII dissolution testing apparatus II. Matrix tablets were carried out in pH 4.5 phosphate buffer, as dissolution medium, for 8 h. Te-3, Te-4 and Te-7 formulations ensure the criteria of The United States Pharmacopeia XXIII for theophylline extended release capsules (Test 2 criteria, apparatus II). The release data fitted to various mathematical models such as, zero order, first order, Higuchi, Hixson Crowell and Korsmeyer-Peppas for the evaluation of the kinetics and mechanism of the drug release. The release mechanism of matrix tablets followed first order release kinetics. The results of the study indicate that new matrix tablets can be promising alternative for the other oral formulations of theophylline.
dc.description.sponsorshipEge Universityen_US
dc.identifier.citationEge, M. A., Üstünda? Okur, N., Karasulu, H. Y. ve Güneri, T. (2016). Development and in vitro evaluation of theophylline loaded matrix tablets prepared with direct compression. Indian Journal of Pharmaceutical Education and Research, 50(2), S45-S51. https://dx.doi.org/10.5530/ijper.50.2.17
dc.identifier.doi10.5530/ijper.50.2.17
dc.identifier.endpageS51
dc.identifier.issn0019-5464
dc.identifier.issue2
dc.identifier.scopusqualityQ3
dc.identifier.startpageS45
dc.identifier.urihttps://dx.doi.org/10.5530/ijper.50.2.17
dc.identifier.urihttps://hdl.handle.net/20.500.12511/5501
dc.identifier.volume50
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherAssociation of Pharmaceutical Teachers of India
dc.relation.ispartofIndian Journal of Pharmaceutical Education and Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectTheophylline
dc.subjectDrug Release
dc.subjectKinetic Evaluation
dc.subjectTablet
dc.subjectDirect Compression
dc.titleDevelopment and in vitro evaluation of theophylline loaded matrix tablets prepared with direct compression
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
ustundag okur, neslihan-2016.pdf
Boyut:
743.13 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: